FOLD. Amicus Therapeutics Announces Positive Pompe Program Updates
AT2220-Enzyme Replacement Therapy (ERT) Co-Administration Increases Pompe Enzyme (rhGAA) Activity in First 3 Dose Cohorts in Phase 2 Study
AT2220 Mitigates ERT-Related Immunogenicity in ex vivo Studies
http://finance.yahoo.com/news/amicus-therapeutics-announces-positive-pompe-113000060.html
AT2220-Enzyme Replacement Therapy (ERT) Co-Administration Increases Pompe Enzyme (rhGAA) Activity in First 3 Dose Cohorts in Phase 2 Study
AT2220 Mitigates ERT-Related Immunogenicity in ex vivo Studies
http://finance.yahoo.com/news/amicus-therapeutics-announces-positive-pompe-113000060.html
The Penny Ticker.
http://investorshub.advfn.com/The-Penny-Ticker-17412/
5-bagger contest on Dawgg.
http://investorshub.advfn.com/%22Dawgg%22-21519/
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
